Does LANADELUMAB Cause Injection site warmth? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site warmth have been filed in association with LANADELUMAB (TAKHZYRO). This represents 0.2% of all adverse event reports for LANADELUMAB.
5
Reports of Injection site warmth with LANADELUMAB
0.2%
of all LANADELUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site warmth From LANADELUMAB?
Of the 5 reports, 5 (100.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Injection site warmth Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB Cause?
Hereditary angioedema (1,343)
Product dose omission issue (555)
Weight decreased (361)
Weight increased (353)
Inappropriate schedule of product administration (318)
Product use issue (229)
Covid-19 (225)
Injection site pain (201)
Insurance issue (172)
Drug ineffective (142)
What Other Drugs Cause Injection site warmth?
ETANERCEPT (4,011)
ADALIMUMAB (1,275)
DUPILUMAB (889)
ENBREL (544)
IXEKIZUMAB (480)
GLATIRAMER (372)
HYDROXYPROGESTERONE CAPROATE (287)
HUMIRA (261)
NALTREXONE (231)
TIRZEPATIDE (213)
Which LANADELUMAB Alternatives Have Lower Injection site warmth Risk?
LANADELUMAB vs LANADELUMAB-FLYO
LANADELUMAB vs LANREOTIDE
LANADELUMAB vs LANSOPRAZOLE
LANADELUMAB vs LANTHANUM
LANADELUMAB vs LANTUS